Predictors of graft longevity in pediatric heart transplantation

Pediatric Cardiology

Volumn 26, Issue 6, 2005, Pages 762-767

  Leman, N R ^a   Levi, D S ^a,b   Alejos, J C ^a   Wetzel, G T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Orthotopic heart transplantation; Pediatric; Risk factors; Tacrolimus

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

BLOOD GROUP TYPING; BODY WEIGHT; CARDIAC GRAFT REJECTION; CARDIOMYOPATHY; CHILD; CONGENITAL HEART DISEASE; CORONARY CARE UNIT; DONOR; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT; PREDICTION; RACE; RECIPIENT; REVIEW; SEX; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS;

CHILD; CORONARY DISEASE; FEMALE; GRAFT SURVIVAL; HEART DEFECTS, CONGENITAL; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TACROLIMUS;

EID: 31144440035     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-0929-0     Document Type: Review

References (16)

1. Armitage JM, Flicker FJ, del Nido P, et al. (1993) A decade (1982-1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. J Thorac Cardiovasc Surg 105:464-472
2. Aziz T, El-Gamel A, Krysiak P, et al. (1999) Risk factors for early mortality, acute rejection and factors affecting first-year survival after heart transplantation. Transplant Proc 30:1912-1914
3. Boucek MM, Edwards LB, Keck BM, et al. (2002) The registry of the International society for Heart and Lung Transplantation: fifth official pediatric report - 2001 - 2002. J Heart Lung Transplant 21:827-840
4. Chin C, Naftel DC, Singh TP, et al. (2004) Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant 23:178-185
5. Crespo-Leiro MG (2004) Tacrolimus in heart transplantation. Transplant Proc 35:1981-1983
6. Gajarsld RJ, Fosenblatt HM, Denfield SW, et al. (1997) Outcomes among pediatric heart transplant recipients. Texas Heart Inst J 24:97-104
7. Hertz MI, Taylor DO, Trulock EP, et al. (2002) The registry of the International Society for Heart and Lung Transplantation: nineteenth official report - 2002. J Heart Lung Transplant 21:950-970
8. Levi D, Marelli D, Plunkett M, et al. (2002) Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. J Heart Lung Transplant 21:60-770
9. McGriffm DC, Naftel DC, Kirklin JK, et al. (1997) Predicting outcome after listing for heart transplantation in children: Pediatric Heart Transplant Group. J Heart Lung Transplant 16:713-722
10. Morrow WR (2000) Cardiomyopathy and heart transplantation in children. Curr Opin Cardiol 15:216-223
11. Parisi F, Carotti A, Esu F, et al. (1998) Intermediate and long-term results after pediatric heart transplantation: incidence and role of pretransplant diagnosis. Transplant Int 11(Suppl 1):S493
12. Penson MG, Winter WE, Flicker FJ, et al. (1999) Tacrolimus-based triple-drug immunosuppression minimizes serum lipid selevations in pediatric cardiac transplant recipients. J Heart Lung Transplant 18:707-713
13. Pollock-Barziv SM, Anthony SJ, Niedra R, et al. (2003) Quality of life and function following cardiac transplantation in adolescents. Transplant Proc 35:2468-2470
14. Reddy SC, Laughlin D, Webber SA (2004) Immunosuppression in pediatric heart transplantation: 2003 and beyond. Curr Treatment Options Cardiovasc Med 5:417-428
15. Seipelt IM, Crawford SE, Rodgers S, et al. (2004) Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin. J Heart Lung Transplant 23:317-322
16. Swenson JM, Fricker FJ, Armitage JM (1995) Immunosuppression switch in transplant recipients: cyclosporine to FK 506. J Am Coll Cardiol 25:1183-1188